Page last updated: 2024-10-17

aminocaproic acid and Heart Failure

aminocaproic acid has been researched along with Heart Failure in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, JR1
Abrams, J1
Frazier, OH1
Radovancevic, R1
Radovancevic, B1
Bracey, AW1
Kindo, MJ1
Gregoric, ID1

Other Studies

1 other study available for aminocaproic acid and Heart Failure

ArticleYear
Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy.
    The Journal of thoracic and cardiovascular surgery, 2006, Volume: 131, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Arterioles; Capillaries; Cardiac Surgi

2006